Labcorp Holdings LH
NYSE LH
$322.83 -1.68 (-0.52%)
As of: Sep 17, 2026 · 3:59 PM EDT

Labcorp Holdings (LH) Cash from Financing Activities (2009 - 2026)

Labcorp Holdings' (LH) quarterly Cash from Financing Activities came in at -$919.9 million in Q2 2026, down 244.02% year-over-year from $638.7 million in Q2 2025, and down 258.47% quarter-over-quarter from $580.5 million in Q1 2026.

Analysis

Labcorp Holdings (LH) Cash from Financing Activities (2009 - 2026) Analysis & Trends

Labcorp Holdings has disclosed Cash from Financing Activities across 18 years of filings, most recently posting -$919.9 million for Q2 2026.

  • In Q2 2026, Cash from Financing Activities fell 244.02% year-over-year to -$919.9 million; the TTM figure through Jun 2026 stood at -$689.3 million (down 553.36% YoY), while the FY2025 annual figure was -$1.5 billion, down 286.82% from the prior year.
  • Cash from Financing Activities came in at -$919.9 million for Q2 2026 at Labcorp Holdings, down from $580.5 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $1.5 billion in Q3 2024 to a low of -$1.9 billion in Q4 2023.
  • Average Cash from Financing Activities over 5 years is -$216.5 million, with a median of -$278.9 million recorded in 2025.
  • Year-over-year, Cash from Financing Activities jumped 422.08% in 2023 and slumped 7076.92% in 2025.
  • Over 5 years, Cash from Financing Activities stood at -$372.6 million in 2022, then slumped by 422.33% to -$1.9 billion in 2023, then jumped by 71.91% to -$546.7 million in 2024, then jumped by 46.88% to -$290.4 million in 2025, then sank by 216.77% to -$919.9 million in 2026.
  • Per Business Quant data, the three most recent Cash from Financing Activities figures were -$919.9 million in Q2 2026, $580.5 million in Q1 2026, and -$290.4 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Natera 49.39 Bn 48.29 Bn 486.15 Mn 12.21 Mn
2 Quest Diagnostics 27.49 Bn 26.86 Bn 1.03 Bn -229.00 Mn
3 Labcorp Holdings 26.51 Bn 26.37 Bn 1.11 Bn -919.90 Mn
4 Guardant Health 23.17 Bn 22.12 Bn 219.03 Mn 23.01 Mn
5 Tempus AI 12.59 Bn 11.77 Bn 274.25 Mn 97.12 Mn
6 Caris Life Sciences 8.01 Bn 7.22 Bn 182.38 Mn -36.90 Mn
7 Sotera Health 5.53 Bn 5.17 Bn 177.96 Mn -2.41 Mn
8 BillionToOne 4.80 Bn 4.25 Bn 77.11 Mn 6.09 Mn
9 Adaptive Biotechnologies 4.40 Bn 4.05 Bn 51.39 Mn 142.19 Mn
10 iRhythm Holdings 3.68 Bn 3.08 Bn 163.21 Mn 4.08 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -919.90 Mn
Mar 31, 2026 580.50 Mn
Dec 31, 2025 -290.40 Mn
Sep 30, 2025 -59.50 Mn
Jun 30, 2025 -267.40 Mn
Mar 31, 2025 -839.70 Mn
Dec 31, 2024 -546.70 Mn
Sep 30, 2024 1.55 Bn
Jun 30, 2024 -210.00 Mn
Mar 31, 2024 -11.70 Mn
Dec 31, 2023 -1.95 Bn
Sep 30, 2023 -1.10 Bn
Jun 30, 2023 1.55 Bn
Mar 31, 2023 -60.60 Mn
Dec 31, 2022 -372.60 Mn
Sep 30, 2022 -452.20 Mn
Jun 30, 2022 -479.70 Mn
Mar 31, 2022 -17.70 Mn
Dec 31, 2021 -1.01 Bn
Sep 30, 2021 -281.70 Mn